Targacept has completed recruitment for two phase IIb clinical trials and expects to start a third phase IIb trial in a third compound in the second quarter.
http://wraltechwire.com/targacept-reports-1q-net-loss-after-astrazeneca-partnership-ends/12419924/
http://wraltechwire.com/targacept-reports-1q-net-loss-after-astrazeneca-partnership-ends/12419924/
No comments:
Post a Comment